FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225689932> ?p ?o ?g. }

• W4225689932 endingPage "e1967" @default.
• W4225689932 startingPage "e1958" @default.
• W4225689932 abstract "Cervical cancer (CC) disproportionately affects minorities who have higher incidence and mortality rates. Standard of care for locally advanced CC involves a multimodality approach including brachytherapy (BT), which independently improves oncologic outcomes. Here, we examine the impact of insurance status and race on BT utilization with the SEER database.In total, 7,266 patients with stage I-IV CC diagnosed from 2007 to 2015 were included. BT utilization, overall survival (OS), and disease-specific survival (DSS) were compared.Overall, 3,832 (52.7%) received combined external beam radiation therapy (EBRT) + BT, whereas 3,434 (47.3%) received EBRT alone. On multivariate logistic regression analysis, increasing age (OR, 0.98; 95% CI, 0.98 to 0.99; P < .001); Medicaid (OR, 0.80; 95% CI, 0.72 to 0.88; P < .001), uninsured (OR, 0.67; 95% CI, 0.56 to 0.80; P < .001), and unknown versus private insurance (OR, 0.61; 95% CI, 0.43 to 0.86; P < .001); Black (OR, 0.68; 95% CI, 0.60 to 0.77; P < .001) and unknown versus White race (OR, 0.30; 95% CI, 0.13 to 0.77; P = .047); and American Joint Committee on Cancer stage II (OR, 1.07; 95% CI, 0.93 to 1.24; P = .36), stage III (OR, 0.82; 95% CI, 0.71 to 0.94; P = .006), stage IV (OR, 0.30; 95% CI, 0.23 to 0.40; P < .001), and unknown stage versus stage I (OR, 0.36; 95% CI, 0.28 to 0.45; P < .001) were associated with decreased BT utilization. When comparing racial survival differences, the 5-year OS was 44.2% versus 50.9% (P < .0001) and the 5-year DSS was 55.6% versus 60.5% (P < .0001) for Black and White patients, respectively. Importantly, the racial survival disparities resolved when examining patients who received combined EBRT + BT, with the 5-year OS of 57.3% versus58.5% (P = .24) and the 5-year DSS of 66.3% versus 66.6% (P = .53) for Black and White patients, respectively.This work demonstrates notable inequities in BT utilization for CC that particularly affects patients of lower insurance status and Black race, which translates into inferior oncologic outcomes. Importantly, the use of BT was able to overcome racial survival differences, thus highlighting its essential value." @default.
• W4225689932 created "2022-05-05" @default.
• W4225689932 creator A5005055916 @default.
• W4225689932 creator A5007465482 @default.
• W4225689932 creator A5022956345 @default.
• W4225689932 creator A5024043125 @default.
• W4225689932 creator A5033392544 @default.
• W4225689932 creator A5040900375 @default.
• W4225689932 creator A5041230511 @default.
• W4225689932 creator A5056347988 @default.
• W4225689932 creator A5063250950 @default.
• W4225689932 creator A5070923889 @default.
• W4225689932 creator A5074488614 @default.
• W4225689932 creator A5085771294 @default.
• W4225689932 date "2021-12-01" @default.
• W4225689932 modified "2023-10-07" @default.
• W4225689932 title "Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities" @default.
• W4225689932 cites W1489849037 @default.
• W4225689932 cites W1494057081 @default.
• W4225689932 cites W1706093900 @default.
• W4225689932 cites W1977357532 @default.
• W4225689932 cites W1996267265 @default.
• W4225689932 cites W2022638262 @default.
• W4225689932 cites W2036158460 @default.
• W4225689932 cites W2038717496 @default.
• W4225689932 cites W2039067005 @default.
• W4225689932 cites W2075481395 @default.
• W4225689932 cites W2076075334 @default.
• W4225689932 cites W2081719471 @default.
• W4225689932 cites W2084220016 @default.
• W4225689932 cites W2093777090 @default.
• W4225689932 cites W2105211307 @default.
• W4225689932 cites W2114212562 @default.
• W4225689932 cites W2126246455 @default.
• W4225689932 cites W2126571024 @default.
• W4225689932 cites W2127043059 @default.
• W4225689932 cites W2132866055 @default.
• W4225689932 cites W2142030764 @default.
• W4225689932 cites W2149155667 @default.
• W4225689932 cites W2159831861 @default.
• W4225689932 cites W2169196520 @default.
• W4225689932 cites W2314753133 @default.
• W4225689932 cites W2331715775 @default.
• W4225689932 cites W2399350062 @default.
• W4225689932 cites W2515493885 @default.
• W4225689932 cites W2516516580 @default.
• W4225689932 cites W2519514651 @default.
• W4225689932 cites W2555242171 @default.
• W4225689932 cites W2581619679 @default.
• W4225689932 cites W2590262500 @default.
• W4225689932 cites W2755205243 @default.
• W4225689932 cites W2766643066 @default.
• W4225689932 cites W2790154392 @default.
• W4225689932 cites W2790706219 @default.
• W4225689932 cites W2800606911 @default.
• W4225689932 cites W2882975303 @default.
• W4225689932 cites W2884165073 @default.
• W4225689932 cites W2888774042 @default.
• W4225689932 cites W2897591663 @default.
• W4225689932 cites W2904991709 @default.
• W4225689932 cites W2906196686 @default.
• W4225689932 cites W2938914306 @default.
• W4225689932 cites W2954705241 @default.
• W4225689932 cites W2968395862 @default.
• W4225689932 cites W2970226356 @default.
• W4225689932 cites W2999417355 @default.
• W4225689932 cites W3000734720 @default.
• W4225689932 cites W3092507800 @default.
• W4225689932 cites W3147894994 @default.
• W4225689932 cites W4205159828 @default.
• W4225689932 cites W4292218564 @default.
• W4225689932 cites W4293241248 @default.
• W4225689932 doi "https://doi.org/10.1200/op.21.00291" @default.
• W4225689932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34550749" @default.
• W4225689932 hasPublicationYear "2021" @default.
• W4225689932 type Work @default.
• W4225689932 citedByCount "14" @default.
• W4225689932 countsByYear W42256899322022 @default.
• W4225689932 countsByYear W42256899322023 @default.
• W4225689932 crossrefType "journal-article" @default.
• W4225689932 hasAuthorship W4225689932A5005055916 @default.
• W4225689932 hasAuthorship W4225689932A5007465482 @default.
• W4225689932 hasAuthorship W4225689932A5022956345 @default.
• W4225689932 hasAuthorship W4225689932A5024043125 @default.
• W4225689932 hasAuthorship W4225689932A5033392544 @default.
• W4225689932 hasAuthorship W4225689932A5040900375 @default.
• W4225689932 hasAuthorship W4225689932A5041230511 @default.
• W4225689932 hasAuthorship W4225689932A5056347988 @default.
• W4225689932 hasAuthorship W4225689932A5063250950 @default.
• W4225689932 hasAuthorship W4225689932A5070923889 @default.
• W4225689932 hasAuthorship W4225689932A5074488614 @default.
• W4225689932 hasAuthorship W4225689932A5085771294 @default.
• W4225689932 hasBestOaLocation W42256899321 @default.
• W4225689932 hasConcept C120665830 @default.
• W4225689932 hasConcept C121332964 @default.
• W4225689932 hasConcept C121608353 @default.
• W4225689932 hasConcept C126322002 @default.
• W4225689932 hasConcept C146357865 @default.

• next